Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2018 Apr 20;22(7):3315–3322. doi: 10.1111/jcmm.13635

Limbal niche cells are a potent resource of adult mesenchymal progenitors

Ping Guo 1, Hong Sun 2, Yuan Zhang 3, Sean Tighe 3, Shuangling Chen 3, Chen‐Wei Su 3, Yongsong Liu 4, Hongxia Zhao 4, Min Hu 5, Yingting Zhu 3,
PMCID: PMC6010802  PMID: 29679460

Abstract

Limbal niche cells located in the limbal Palisades of Vogt are mesenchymal stem cells that reside next to limbal basal epithelial cells. Limbal niche cells are progenitors that express embryonic stem cell markers such as Nanog, Nestin, Oct4, Rex1, Sox2 and SSEA4, mesenchymal cell markers such as CD73, CD90 and CD105, and angiogenesis markers such as Flk‐1, CD31, CD34, VWF, PDGFRβ and α‐SMA, but negative for CD45. In addition, the stemness of limbal niche cells can be maintained during their cell culture in a three‐dimension environment. Furthermore, expanded limbal niche cells have the capability to undergo adipogenesis, chondrogenesis, osteogenesis and endogenesis in vitro, indicating that they are in fact a valuable resource of adult progenitors. Furthermore studies on how the limbal niche cells regulate the aforementioned stemness and corneal fate decision are warranted, as those investigations will shed new light on how mesenchymal progenitors reverse limbal stem cell deficiency and lead to new methods for limbal niche cell treatment.

Keywords: cell‐based therapy, differentiation, limbal stem cell deficiency, limbus, niche, stem cell

1. HUMAN LIMBUS

Anatomically the limbal stem cell (SC) niche is located in the region termed Palisades of Vogt. Unlike the structure in the cornea, the basement membrane from the limbus is interconnecting with the stroma,1 and the limbal basal epithelial cells have invaginations through the basement membrane to connect with the underlying matrix,2 suggesting that limbal epithelial SC keep close contact with the limbal stroma cells. Limbal SC extends into the limbal stroma, forming a structure called “limbal epithelial crypt” (LEC).1 Interestingly, limbal crypts are encircled by focal stromal projections (FSP), circulating down the projections of the limbal epithelium closely linked to the limbal vasculature.3 Such limbal epithelial progenitor cells (LEPC) retain their progenitor status in the limbal niche environment (reviewed in 4). When malfunctions among limbal niche cells (LNC) and LEPC occur, it causes a state of limbal stem cell deficiency (LSCD), leading to symptoms such as redness, irritation, photophobia, decreased vision from corneal opacity and irregular astigmatism (reviewed in 5). The aetiology for LSCD remains unclear.

2. HETEROGENEITY OF LIMBAL STEM CELLS

Previous studies indicate that limbal SC are distributed in the limbal basal layer heterogeneously, suggesting a heterogeneously localization of the limbal niche. The limbal basal epithelial cells heterogeneously express Vim,6 ΔNp63α,7 ABCG2,8 C/EBPδ and Bmi‐1,9 while homogeneously expressing CK15 that extends to conjunctival basal epithelial cells.10 N‐cadherin can also be expressed by putative stem cells or progenitors as well as melanocytes in the human limbal epithelial SC niche.11 Cx43, on the other hand, is well demonstrated to be a negative marker of limbal SC, but found positive in epithelial cells in LEC.1 However, it remains unclear how the aforementioned SC and molecules modulate the quiescent and/or active stage of limbal epithelial SC.

3. ISOLATION AND EXPANSION OF HUMAN LIMBAL NICHE CELLS

The limbal stem cell niche is a structure of the ocular surface that is characterized by high specification, organization and clinical significance (Reviewed in 12). Limbal stromal niche cells expressing SC markers can be isolated and expanded without differentiation and maintain clonal growth of limbal epithelial progenitors.13 Culture of such cells on denuded amniotic membrane can maintain native niche cells14 and quiescence.15 Several types of cells enriched in the limbal niche may serve as niche cells, including melanocytes,11 blood vascular endothelial cells3 and neural cells.16 Although the presence of niche cells (NC) is implicated by the aforementioned studies, it has not been identified until recently when a novel isolation method using collagenase A was used.17 This method helps to identify putative NC as small Vim positive stromal cells in the form of cell clusters.17, 18 In addition, expansion of the niche/stem cell population isolated from collagenase A digestion is more efficient than single cell suspension by trypsin/EDTA digestion based on the number of p63α positive cells,19 suggesting that an intact cell‐cell contact help to maintain LSC in an undifferentiated state in vitro during expansion. Compared to the method of dispase digestion which removes intact sheets of limbal epithelium 20 but not all limbal epithelial progenitors, collagenase A digestion removes the entire progenitors in the limbal basal area which express ESC markers such as Nanog, Oct4 and Sox2.18 In addition, collagenase A digestion has been performed without shaking, as shaking is not as effective in the concept of releasing progenitor cells.21

Modified embryonic stem cell medium (MESCM) is considered an optimal medium for expansion of limbal niche cells. MESCM is comprised of DMEM/F‐12 (1:1) but supplemented with 10% knockout serum, 5 μg/mL insulin, 5 μg/mL transferrin, 5 ng/mL sodium selenite, 4 ng/mL bFGF and 10 ng/mL hLIF, which is similar to another widely used medium containing DMEM‐F12, knockout serum, basic fibroblast growth factor and leukaemia inhibitory factor (LIF) which produces a cell phenotype closest to that of a pluripotent stem cells.22 In fact, such stem cells in the limbal niche have been confirmed (for review, see 23 and 24). Maintenance of close association between the epithelial and niche cells lead to clonal growth in a low‐calcium, serum‐free medium while disruption of this linkage with trypsin/EDTA abolishes clone growth unless cocultured with 3T3 feeder layers.17 Interestingly, Bhartiya et al25 have isolated a group of stem cells, named very small embryonic‐like stem cells (VSEL). The phenotype of such potent cells includes a very small size (3‐5 μm), high nucleo‐cytoplasmic ratio, and expression of Oct‐4, SSEA‐4, and other pluripotent markers such as Nanog, Sox‐2, Rex‐1 and Tert.25 Similarly, on epithelial‐denuded amniotic membrane, maintenance of such linkage may cause extensive epithelial outgrowth, which can be attenuated by trypsin/EDTA treatment.17 Epithelial outgrowth from the clusters obtained from collagenase digestion may be significantly larger. In addition, single cells obtained from clonal growth may generate more holoclones when cultured on 3T3 fibroblast feeder layers than those obtained from dispase digestion,17 suggesting that these cells are indeed young progenitors. Interestingly, human corneal stromal progenitors exhibit survival capacity following isolation from a stored organ.26 Furthermore, mesenchymal stromal progenitors cultivated from the limbus display immunosuppressive qualities in addition to their established non‐immunogenic profile and stimulate limbal epithelial cell growth in vitro across species boundaries.27 Using a novel method of serial passages on a 2D Matrigel system, we further isolated and expanded LNC to up to 12 passages with 33 population doublings and characterized them as angiogenesis progenitors when cultured in embryonic stem cell medium (ESCM) with fibroblast growth factor‐basic (bFGF) and LIF.28 The cells are thought to be angiogenesis progenitors due of up‐regulation of these specific progenitor markers when the cells are reseeded in 3D Matrigel.28 These cells may be differentiated into vascular endothelial cells along with pericytes for stabilization of tube network generated by human umbilical vein endothelial cells (HUVEC).28 Interestingly, stromal cells which express a number of angiogenesis markers are located perivascularly, next to epithelial cells in the limbal basal area.29 If cultured in a 3D Matrigel system, the stromal cells obtained by dispase/collagenase digestion but not the stromal cells at the limbal residual area may form the spheres with angiogenesis progenitors to maintain vascular networks.29 Such sphere‐forming cells from peripheral cornea demonstrate the ability to repopulate the ocular surface, expressing stem cell markers such as ΔNp63α, ABCG2, ABCB5 as well as the basal limbal and putative niche marker notch 1.30 Similar to the cells obtained by collagenase digestion, the cells obtained from dispase/collagenase digestion may also proliferate when cultured on 2D Matrigel for 12 passages. As a result, the spindle cells may express the specific markers of MSC and angiogenesis, have higher ability to form colonies, and retain higher efficiency of tri‐lineage differentiation, when compared to the stromal cells isolated by dispase/collagenase digestion from the limbal residual area when cultured in DMEM containing 10% fetal bovine serum (FBS).29 Although limbal NC or HUVEC may reunite with LEPC to generate the spheres with higher expression of CK15, C/EBPδ and ΔNp63α, limbal NC but not HUVEC can attenuate over‐expression of CK12 keratin in LEPC.28 Those findings raise the hypothesis that a vascular niche also exist in the human limbal niche. The above findings also suggest that we may devise another novel method of separating limbal basal epithelial cells into two compartments, that is, one removed solely by dispase and the other that dispase cannot remove. The latter can be obtained by collagenase A digestion.

4. HUMAN LIMBAL NICHE CELLS AS ANGIOGENESIS PROGENITORS

4.1. Vascular/SC niche

The vascular niche refers to a microenvironment that is generated by vascular endothelial cells (VEC), pericytes and bone marrow (BM) cells.31 The unique perivascular localization of the central neural system, the bone marrow and the testis suggests that vascular niche plays a critical role within the SC niche.32, 33, 34 Vascular endothelium can also support bone marrow SC in the central nervous system, the muscle and the pancreatic islets.35 The mechanisms involved include the physical contact and the paracrine factors such as bFGF, IGFBP2, angiopoietin‐1 (Ang1), BMP4, DHH, PEDF, NDEF, FGF4 and SDF‐1.32 VEC are derived from their endothelial progenitor cells (EPC). Vascular BM, composed of collagen IV, laminin, nidogens, heparin sulfate proteoglycan and growth factors such as FGF, TGFβ, IGF, PDGF, EGF are a key part of all vascular niches. Adult tissue needs a highly selective extracellular matrix (ECM) to maintain their SC properties particularly during development.33 For example, human ESC may retain their undifferentiated state when cultured on Matrigel.34 BM can also improve the proliferation and differentiation of human MSC in vitro.36 For instance, collagen IV may promote the differentiation potential of ESC to EPC37 whereas laminin can promote insulin gene expression and proliferation in beta islet cells, and beta1‐integrin is required for the beta islet cell response to laminin's signals from VEC.38 Hematopoietic stem cells (HSC) may shift from a quiescent osteoblastic niche to a vascular niche to support their proliferation and further differentiation in the bone marrow.32 Previously, we have isolated and expanded a group of limbal niche cells on 2D Matrigel in MESCM. We attribute the success of the isolation and expansion of LNC to 2D Matrigel culture, as the expanded cells are in contact with the basement membrane continuously.

4.2. Pericytes, smooth muscle cells and vascular niche

There are two kinds of mural vessel cells (pericytes and smooth muscle cells [SMC]) which share a similar function of controlling the vessel contraction and new blood vessel generation. Pericytes make specific cell‐to‐cell contacts with VEC of capillaries, postcapillary venues, precapillary arterioles, and collecting venules, while SMC are distributed in the middle layer of bigger vessel walls. In fact, pericytes are an important compartment of the vascular niche because of their contribution to MSC39 and ability to produce BM.40 Pericytes may also be recruited during formation of vasculogenic tube assembly in order to stimulate endothelial BM formation, and are enveloped by BM, indicating the essential requirement of BM for the pericyte niche.41 Pericytes also give rise to astrocytes and deposit ECM in the injured spinal cord.42 Central neural system (CNS) pericytes can differentiate into macrophage/dendritic cells, antigen presenting cells, and MSC.43 Nevertheless, it is unclear whether pericytes may serve as limbal NC.

Multi‐potential MSC derived from human tissues, including adipose tissue and skeletal muscle, appear to be derived nearly exclusively from perivascular SMC‐pericytes.44, 45, 46 A variety of contractile proteins are important for the differentiated function of the SMC, including α‐SMA, smooth muscle (SM) myosin heavy chains (MHC), SM myosin light chains, h1‐calponin and SM α‐tropomyosin. In addition, differentiated SMC express a number of proteins that are part of the cytoskeleton and/or are involved in the regulation of contraction molecules such as h‐calponin, SM22α, h‐caldesmon, β‐vinculin, metavinculin, telokin, smoothelin, LPP and desmin. Interestingly, virtually all of these SMC differentiation markers can also be expressed in non‐SMC under some conditions, with the possible exception of the SM MHC isoforms,47 which appear to be the most specific markers of differentiated SMC.45

Pericytes represent a unique subtype of perivascular cells with multi‐lineage developmental features and various angiogenic functions.48 As the ancestor of MSC, pericytes can not only give rise to MSC, but also contribute indirectly to tissue regeneration, possibly by promotion of angiogenesis and elimination of inflammation of endogenous progenitor cells. Therefore, pericytes could be applied as alternative therapeutic cells in replacement of MSC for regenerative medicine.49 In order to select the right cell type, there are clues for the relation between the marker pattern and the multipotent potential of such cells. For example, PDGFRβ‐expressing cells are perivascular cells distinct from mature pericytes due to their ability to differentiate into mature pericytes and to support vascular tube stability and survival in vitro.50 Most pericytes in vivo are α‐SMA negative 51 except those located near arterioles are routinely α‐SMA positive.52 Interestingly, less than 5% of freshly isolated capillary pericytes express α‐SMA, but nearly 100% express this marker in 7 days in culture with serum.53 Human and rat brain pericytes are positive for stem cell markers such as NG2 and nestin.43 CD146 can be used in isolating pericytes expressing PDGFR‐β, α‐SMA and NG2 from human skeletal muscle, pancreases, placenta, heart, skin, lung, brain, eye, gut, bone marrow and umbilical cord.44 Although some markers are commonly used for progenitor cell identification, such as α‐SMA, PDGFR‐β, NG2, RGS5, aminopeptidase A and N5‐7, those markers are not universal, but rather specific to the developmental stage, tissue bed, and even species.54 ACTA2, SMAA, SM22, MYOCD, MYH11, SMMHC and CNN1 could be used to identify the presence of SMC.46 The in vitro data support the concept that in the correct environment, CNS pericytes may differentiate to MSC and then differentiate to bone, adipocytes, smooth muscle, and VEC when cultured in a medium containing 10% FBS and 50 ng/mL vascular endothelial growth factor (VEGF).52 ESC could turn into Flk‐1 positive vascular progenitors and further differentiate into VEC in the presence of VEGF or SMC and PDGFβ.37

4.3. Endothelial progenitor cells and the stem cell niche

Endothelial progenitor cells (EPC) can be found and replicated from human limbus for tissue engineering purposes.55, 56 EPC is also an important angiogenesis progenitor cells identified to be positive for Flk‐1, CD34, CD31, CD73, CD90, CD105, CD144 and negative for CD10, CD13, CD29, CD44. CD31 is the key marker of EPC and mature VEC, identified as a regulator of adhesion, migration and activation.57 Flk1 is the earliest marker of angioblast precursors, specifically for a subset of cells that migrate into the extraembryonic yolk sac to form the vascular plexus during the murine development.58 Foetal mouse lung mesenchymal cells with the highest Flk‐1 expression can be differentiated into endothelium more efficiently.59 EPC could be isolated from bone marrow, blood60 and non‐BM adult tissues, including skeletal muscle, adipose, spleen, liver, intestine and myocardium.61 In the bone marrow, EPC derive from bone marrow stem cells and exist as residential progenitor cells. Such stem cells in limbal stroma are in fact multi‐functional niche cells23 and interact with limbal epithelial cells to exert their functions.24, 62 Limbal ESC obtained from young donors may produce better stem cells for clinical therapies.63 Sphere forming cells are also a promising cell type for stem cell repopulations 30, 64 and native LNC may promote the expansion of LEPC.19 Human corneal stromal SC may survive in stored organ or culture,26 although biomechanics exhibit a powerful effect on LNC and their growth and differentiation.12 Human corneal stromal SC may prevent corneal scarring.65 Stem cells and niche cells may interact with cell adhesive molecules to exert their functions.66 Corneal stromal SC can even be induced to functional corneal endothelium by activation of Wnt signalling.67 Human corneal stromal SC can also support limbal epithelial cells in vitro.68 However, it is unclear whether EPC could serve as SC niche cells or serve as limbal niche cells.

5. HUMAN LIMBAL NICHE CELLS AS A SOURCE OF MESENCHYMAL PROGENITORS

MSC clusters represent an important component of the limbal‐niche.29 MSC have great potential for regenerative medicine due to their high plasticity, self‐renewal, specific immune response and the ability for genetic modification. Therefore, the growing demand for cell‐based therapy necessitates a massive production of MSC. According to the minimum criteria set by the International Society for Cellular Therapy, MSC should be (i) adhere to plastic, (ii) express of specific surface antigens such as CD73, CD90 and CD105 positive, CD45 and CD34 negative, and (iii) have multi‐lineage differentiation potential, for example, to adipocyte, chondrocytes and osteocyte.69 Although first isolated from the bone marrow,70 MSC could virtually be obtained from all adult tissues.39, 71 MSC are located in perivascular sites of many tissues such as in the bone marrow,43 in adipose tissue, placenta and skeletal muscle44 and in the dental pulp.72 Functional corneal endothelial cells could be derived from corneal stroma stem cells of neural crest origin by retinoic acid and activation of Wnt/β‐Catenin Signalling.67 MSC could also be derived from the human limbal niche.28, 29

The cell origin of the MSC, that is, the progenitor cells of MSC, has not been very well‐defined. However, recent evidence indicates that the progenitor cells of MSC lie in a parivascular niche and that MSC derive from the pericytes, or perivascular progenitor cells.39, 44 Pericytes and MSC express the cell markers in their native state, for example, α‐SMA, CD44, CD73, CD90 and CD105, NG2, PDGFR‐β and stromal progenitor antigen‐1 (STRO‐1) but not CD45, CD31.44, 72, 73, 74, 75 In in vitro culture, pericytes display an MSC‐like phenotype, with respect to morphology, clonal growth, self‐renewal and tri‐lineage differentiation to different tissues such as bone, cartilage, fat,44 nervous tissue43 and skeletal muscle.73, 76 Meanwhile, MSC could be induced into EPC by VEGF, expressing Flk‐1, CD34 and CD31.77 Human bone marrow derived MSC express CD31, α‐SMA and smoothelin upon interaction with endothelial cell matrix.78 Under serum‐deprived conditions, human bone marrow derived MSC express prosurvival and angiogenic factors including VEGF‐A, ANGPTs, IGF‐1 and HGF, and a population of these cells have the potential to differentiate into endothelial like cells.79 Multipotent foetal mouse lung mesenchymal cells with the highest Flk‐1 expression may be differentiated into endothelia more efficiently.59

MSC could also be isolated from the niche of epithelial stem cells80 or differentiated from embryonic stem cells,54 while pericytes, which is believed to be the origin of MSC, could also be differentiated from human pluripotent SC.48 Sox2 positive skin‐derived precursors, which localize in the niche of the hair papillae and whisker follicles, represent an endogenous embryonic precursor cells that exhibit multipotency properties similar to embryonic neural‐crest stem cells80 and can be easily differentiated into functional vascular smooth muscle cells (SMC) in a serum‐free condition. Based on the marker expression pattern of isolated MSC, a group of stem cell markers including Oct4, PDGFRβ and SSEA4 may be detected in the primary but not expanded MSC,81 indicating that Oct4, PDGFRβ and SSEA4 may be used as the specific markers of MSC. However, different markers used in isolating MSC from different types of tissue are problematic for identification and comparison of the similarity and differences reported from various authors.

It has been well documented that MSC within the niche of hematopoietic stem cells is a critical component of the SC niche. MSC contribute to the complex structure of the hematopoietic niche by differentiating into osteoblasts and by supporting HSC proliferation and self‐renewal by themselves. MSC also participate in the hematopoietic process through releasing paracrine signalling factors.82 Both pericytes and MSC can provide mechanical and paracrine support to other cell types.83 It is unclear whether the limbal niche derived MSC could serve as niche cells for the epithelial SC. Another notion noticed is that MSC may be tissue specific, thus we may speculate that LNC, which is progenitor cells of both MSC and angiogenesis progenitor cells, may act as the best support cells than other tissue derived MSC.

6. GROWTH FACTORS AND OTHER ACTIVE LIGANDS AFFECTING BEHAVIOUR OF LIMBAL NICHE CELLS

Growth factors such as bFGF and TGF‐β3 may induce multilayered lamellae with orthogonally oriented collagen fibrils and the human corneal stromal tissue. The approach of combining the effect of growth factors and substrates provides a new regenerative approach for corneal regeneration and medical treatment.84 PDGF and VEGF can affect cell differentiation from ESC. Flk‐1 positive progenitor cells from ESC may be induced into VEC by VEGF.37 Pericytes isolated from CNS may differentiate to MSC and then differentiate to bone, adipocytes, smooth muscle and VEC with 10% fetal calf serum and 50 ng/mL VEGF.52 The influence of VEGF and PDGF on the outcome of angiogenesis progenitor expansion from the human limbus is not clear. BMP4 synergizes with LIF to maintain self‐renewal by activating JAK/Stat3 signalling in mouse ES cells in the presence of serum.85 In the absence of serum, BMP synergizes with LIF to maintain self‐renewal in mouse ES cells through induction of gene expression of ID genes.86 In an in vitro reunion model of LEPC and LNC in 3D Matrigel, LEPC+LNC spheres shows their ability of significantly higher clonal growth and dramatic lower differentiation in corneal epithelium.87 In such a culture, nuclear translocation of pSmad1/5/8 is observed in LEPC, but not in LNC. Such a nuclear translocation of pSmad1/5/8 is associated with activation of canonical BMP signalling.87 In addition, β‐catenin was stabilized in the perinuclear cytoplasm in LEPC and correlated with up‐regulation of Wnt7A and FZD5 preferentially expressed by LEPC.87 Interestingly, addition of BMP inhibitor noggin inhibits canonical BMP signalling but activates canonical Wnt signalling, indicating balancing action of canonical Wnt signalling and canonical BMP signalling between LNC and LEPC mediates clonal growth of LEPC.87 It is unclear whether canonical BMP signalling is also involved in induction of ESC like cells in the human limbus into angiogenesis progenitors.

7. ANIMAL MODELS TO STUDY DEFICIENCY OF LIMBAL NICHE CELL DYSFUNCTION

Recently, a mice model was established to study the mechanisms of limbal stem cell deficiency (LSCD), suggesting that the phenotype of LSCD in the mouse model was maintained for more than 3 months.88 A rabbit model was also established for potential use of limbal MSC to treat corneal disorders.27

8. SUMMARY

Limbal niche cells are another source of local mesenchymal stem cells located in the limbal Palisades of Vogt, next to limbal basal epithelial cells. The cells are as small as 5 μm in diameter. Limbal niche cells can be isolated from the human limbus by collagenase digestion and cultured in DMEM plus 10% FBS or in MESCM with bFGF and LIF on plastic, on 2D Matrigel, or on 3D Matrigel. Characteristically limbal niche cells are positive for various stem cell markers (Oct4, Sox2, Nanog, Rex1, SSEA4, Nestin and N‐cadherin), mesenchymal cell markers (CD73, CD90, and CD105), and angiogenesis markers (α‐SMA, CD31, CD34, Flk‐1, PDGFRβ and VWF), but negative for CD45. The expanded LNC are capable of differentiating into adipocytes, osteoblasts and chondrocytes in vitro. Recently, we have successfully isolated human LNC by collagenase digestion of the entire limbal tissue. We have demonstrated LNC express cell markers for BMMSC and ESC, indicating that they may be the progenitor cells for MSC. Furthermore, LSC/LEPC could be maintained during the culture process of LSC/LEPC in a three‐dimension environment. Furthermore studies on how the LNC may regulate the stemness of LEPC and the decision of corneal fate are warranted, which may shed new light on how MSC are used for treatment of diseases with stem cell deficiency, for example, managing to reverse LSCD. The primary functions of LNC are summarized as Figure 1:

Figure 1.

Figure 1

Summary of Limbal Niche Cell Function. Limbal niche cells are an important source of mesenchymal stem cells located in the limbal palisades of vogt, next to limbal basal epithelial cells. The stemness of limbal niche cells could be maintained during their culture in a three‐dimension environment. The expanded limbal niche cells have the capability to undergo adipogenesis, chondrogenesis osteogenesis and endogenesis in vitro, indicating that they are in fact a valuable resource of adult progenitors

CONFLICT OF INTEREST

The authors confirm that there is no conflict of interest.

ACKNOWLEDGEMENTS

This work was supported by Grant 2015A030313774, Natural Science Fund of Guangdong Province, China.

Guo P, Sun H, Zhang Y, et al. Limbal niche cells are a potent resource of adult mesenchymal progenitors. J Cell Mol Med. 2018;22:3315–3322. https://doi.org/10.1111/jcmm.13635

REFERENCES

  • 1. Shanmuganathan VA, Foster T, Kulkarni BB, et al. Morphological characteristics of the limbal epithelial crypt. Br J Ophthalmol. 2007;91:514‐519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Chen Z, de Paiva CS, Luo L, Kretzer FL, Pflugfelder SC, Li DQ. Characterization of putative stem cell phenotype in human limbal epithelia. Stem Cells. 2004;22:355‐366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Shortt AJ, Secker GA, Munro PM, Khaw PT, Tuft SJ, Daniels JT. Characterization of the limbal epithelial stem cell niche: novel imaging techniques permit in vivo observation and targeted biopsy of limbal epithelial stem cells. Stem Cells. 2007;25:1402‐1409. [DOI] [PubMed] [Google Scholar]
  • 4. Zhang Y, Sun H, Liu Y, et al. The limbal epithelial progenitors in the limbal niche environment. Int J Med Sci. 2016;13:835‐840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Kim KH, Mian SI. Diagnosis of corneal limbal stem cell deficiency. Curr Opin Ophthalmol. 2017;28:355‐362. [DOI] [PubMed] [Google Scholar]
  • 6. Hayashida Y, Li W, Chen YT, et al. Heterogeneity of limbal basal epithelial progenitor cells. Cornea. 2010;29(Suppl 1):S32‐S40. [DOI] [PubMed] [Google Scholar]
  • 7. Wang DY, Cheng CC, Kao MH, Hsueh YJ, Ma DH, Chen JK. Regulation of limbal keratinocyte proliferation and differentiation by TAp63 and DeltaNp63 transcription factors. Invest Ophthalmol Vis Sci. 2005;46:3102‐3108. [DOI] [PubMed] [Google Scholar]
  • 8. de Paiva CS, Chen Z, Corrales RM, Pflugfelder SC, Li DQ. ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells. Stem Cells. 2005;23:63‐73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Barbaro V, Testa A, Di Iorio E, Mavilio F, Pellegrini G, De Luca M. C/EBPdelta regulates cell cycle and self‐renewal of human limbal stem cells. J Cell Biol. 2007;177:1037‐1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Yoshida S, Shimmura S, Kawakita T, et al. Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci. 2006;47:4780‐4786. [DOI] [PubMed] [Google Scholar]
  • 11. Hayashi R, Yamato M, Sugiyama H, et al. N‐Cadherin is expressed by putative stem/progenitor cells and melanocytes in the human limbal epithelial stem cell niche. Stem Cells. 2007;25:289‐296. [DOI] [PubMed] [Google Scholar]
  • 12. Eberwein P, Reinhard T. Concise reviews: the role of biomechanics in the limbal stem cell niche: new insights for our understanding of this structure. Stem Cells. 2015;33:916‐924. [DOI] [PubMed] [Google Scholar]
  • 13. Xie HT, Chen SY, Li GG, Tseng SC. Isolation and expansion of human limbal stromal niche cells. Invest Ophthalmol Vis Sci. 2012;53:279‐286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Chen SY, Mahabole M, Tseng SC. Optimization of ex vivo expansion of limbal epithelial progenitors by maintaining native niche cells on denuded amniotic membrane. Transl Vis Sci Technol. 2013;2:1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Chen SY, Han B, Zhu YT, et al. HC‐HA/PTX3 purified from amniotic membrane promotes bmp signaling in limbal niche cells to maintain quiescence of limbal epithelial progenitor/stem cells. Stem Cells. 2015;33:3341‐3355. [DOI] [PubMed] [Google Scholar]
  • 16. Lawrenson JG, Ruskell GL. The structure of corpuscular nerve endings in the limbal conjunctiva of the human eye. J Anat. 1991;177:75‐84. [PMC free article] [PubMed] [Google Scholar]
  • 17. Chen SY, Hayashida Y, Chen MY, Xie HT, Tseng SC. A new isolation method of human limbal progenitor cells by maintaining close association with their niche cells. Tissue Eng Part C Methods. 2011;17:537‐548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Xie HT, Chen SY, Li GG, Tseng SC. Limbal epithelial stem/progenitor cells attract stromal niche cells by SDF‐1/CXCR4 signaling to prevent differentiation. Stem Cells. 2011;29:1874‐1885. [DOI] [PubMed] [Google Scholar]
  • 19. Gonzalez S, Deng SX. Presence of native limbal stromal cells increases the expansion efficiency of limbal stem/progenitor cells in culture. Exp Eye Res. 2013;116:169‐176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Espana EM, Romano AC, Kawakita T, Di Pascuale M, Smiddy R, Tseng SC. Novel enzymatic isolation of an entire viable human limbal epithelial sheet. Invest Ophthalmol Vis Sci. 2003;44:4275‐4281. [DOI] [PubMed] [Google Scholar]
  • 21. Chen SY, Mahabole M, Horesh E, Wester S, Goldberg JL, Tseng SC. Isolation and characterization of mesenchymal progenitor cells from human orbital adipose tissue. Invest Ophthalmol Vis Sci. 2014;55:4842‐4852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Sidney LE, Branch MJ, Dua HS, Hopkinson A. Effect of culture medium on propagation and phenotype of corneal stroma‐derived stem cells. Cytotherapy. 2015;17:1706‐1722. [DOI] [PubMed] [Google Scholar]
  • 23. Funderburgh JL, Funderburgh ML, Du Y. Stem cells in the limbal stroma. Ocul Surf. 2016;14:113‐120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Dziasko MA, Daniels JT. Anatomical features and cell‐cell interactions in the human limbal epithelial stem cell niche. Ocul Surf. 2016;14:322‐330. [DOI] [PubMed] [Google Scholar]
  • 25. Bhartiya D, Shaikh A, Nagvenkar P, et al. Very small embryonic‐like stem cells with maximum regenerative potential get discarded during cord blood banking and bone marrow processing for autologous stem cell therapy. Stem Cells Dev. 2012;21:1‐6. [DOI] [PubMed] [Google Scholar]
  • 26. Kureshi AK, Funderburgh JL, Daniels JT. Human corneal stromal stem cells exhibit survival capacity following isolation from stored organ‐culture corneas. Invest Ophthalmol Vis Sci 2014;55:7583‐7588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Bray LJ, Heazlewood CF, Munster DJ, Hutmacher DW, Atkinson K, Harkin DG. Immunosuppressive properties of mesenchymal stromal cell cultures derived from the limbus of human and rabbit corneas. Cytotherapy. 2014;16:64‐73. [DOI] [PubMed] [Google Scholar]
  • 28. Li GG, Chen SY, Xie HT, Zhu YT, Tseng SC. Angiogenesis potential of human limbal stromal niche cells. Invest Ophthalmol Vis Sci. 2012;53:3357‐3367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Li GG, Zhu YT, Xie HT, Chen SY, Tseng SC. Mesenchymal stem cells derived from human limbal niche cells. Invest Ophthalmol Vis Sci. 2012;53:5686‐5697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Mathan JJ, Ismail S, McGhee JJ, McGhee CN, Sherwin T. Sphere‐forming cells from peripheral cornea demonstrate the ability to repopulate the ocular surface. Stem Cell Res Ther. 2016;7:81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Nikolova G, Strilic B, Lammert E. The vascular niche and its basement membrane. Trends Cell Biol. 2007;17:19‐25. [DOI] [PubMed] [Google Scholar]
  • 32. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda). 2005;20:349‐356. [DOI] [PubMed] [Google Scholar]
  • 33. Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci. 2008;121:255‐264. [DOI] [PubMed] [Google Scholar]
  • 34. Fujiwara H, Hayashi Y, Sanzen N, et al. Regulation of mesodermal differentiation of mouse embryonic stem cells by basement membranes. J Biol Chem. 2007;282:29701‐29711. [DOI] [PubMed] [Google Scholar]
  • 35. Christov C, Chretien F, Abou‐Khalil R, et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell. 2007;18:1397‐1409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Lindner U, Kramer J, Behrends J, et al. Improved proliferation and differentiation capacity of human mesenchymal stromal cells cultured with basement‐membrane extracellular matrix proteins. Cytotherapy. 2010;12:992‐1005. [DOI] [PubMed] [Google Scholar]
  • 37. Yamashita J, Itoh H, Hirashima M, et al. Flk1‐positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408:92‐96. [DOI] [PubMed] [Google Scholar]
  • 38. Nikolova G, Jabs N, Konstantinova I, et al. The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell. 2006;10:397‐405. [DOI] [PubMed] [Google Scholar]
  • 39. Caplan AI. All MSCs are pericytes? Cell Stem Cell. 2008;3:229‐230. [DOI] [PubMed] [Google Scholar]
  • 40. Paquet‐Fifield S, Schluter H, Li A, et al. A role for pericytes as microenvironmental regulators of human skin tissue regeneration. J Clin Invest. 2009;119:2795‐2806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood. 2009;114:5091‐5101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J. A pericyte origin of spinal cord scar tissue. Science. 2011;333:238‐242. [DOI] [PubMed] [Google Scholar]
  • 43. Dore‐Duffy P, Katychev A, Wang X, Van Buren E. CNS microvascular pericytes exhibit multipotential stem cell activity. J Cereb Blood Flow Metab. 2006;26:613‐624. [DOI] [PubMed] [Google Scholar]
  • 44. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3:301‐313. [DOI] [PubMed] [Google Scholar]
  • 45. Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13‐40. [DOI] [PubMed] [Google Scholar]
  • 46. Basu J, Genheimer CW, Guthrie KI, et al. Expansion of the human adipose‐derived stromal vascular cell fraction yields a population of smooth muscle‐like cells with markedly distinct phenotypic and functional properties relative to mesenchymal stem cells. Tissue Eng Part C Methods. 2011;17:843‐860. [DOI] [PubMed] [Google Scholar]
  • 47. Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994;75:803‐812. [DOI] [PubMed] [Google Scholar]
  • 48. Dar A, Domev H, Ben‐Yosef O, et al. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation. 2012;125:87‐99. [DOI] [PubMed] [Google Scholar]
  • 49. Crisan M, Corselli M, Chen CW, Peault B. Multilineage stem cells in the adult: a perivascular legacy? Organogenesis. 2011;7:101‐104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Song S, Ewald AJ, Stallcup W, Werb Z, Bergers G. PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat Cell Biol. 2005;7:870‐879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Balabanov R, Dore‐Duffy P. Role of the CNS microvascular pericyte in the blood‐brain barrier. J Neurosci Res. 1998;53:637‐644. [DOI] [PubMed] [Google Scholar]
  • 52. Dore‐Duffy P. Pericytes: pluripotent cells of the blood brain barrier. Curr Pharm Des. 2008;14:1581‐1593. [DOI] [PubMed] [Google Scholar]
  • 53. Dore‐Duffy P. Isolation and characterization of cerebral microvascular pericytes. Methods Mol Med. 2003;89:375‐382. [DOI] [PubMed] [Google Scholar]
  • 54. Boyd NL, Nunes SS, Jokinen JD, et al. Microvascular mural cell functionality of human embryonic stem cell‐derived mesenchymal cells. Tissue Eng Part A. 2011;17:1537‐1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Lu WJ, Tseng SC, Chen S, et al. Senescence mediated by p16INK4a impedes reprogramming of human corneal endothelial cells into neural crest progenitors. Sci Rep. 2016;6:35166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Liu Y, Sun H, Hu M, et al. Human Corneal Endothelial Cells Expanded In Vitro Are a Powerful Resource for Tissue Engineering. Int J Med Sci. 2017;14:128‐135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Ultrastructural localization of platelet endothelial cell adhesion molecule (PECAM‐1, CD31) in vascular endothelium. J Histochem Cytochem. 2004;52:87‐101. [DOI] [PubMed] [Google Scholar]
  • 58. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood‐island formation and vasculogenesis in Flk‐1‐deficient mice. Nature. 1995;376:62‐66. [DOI] [PubMed] [Google Scholar]
  • 59. Yamamoto Y, Baldwin HS, Prince LS. Endothelial differentiation by multipotent fetal mouse lung mesenchymal cells. Stem Cells Dev. 2012;21:1455‐1465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Huertas A, Palange P. Circulating endothelial progenitor cells and chronic pulmonary diseases. Eur Respir J. 2011;37:426‐431. [DOI] [PubMed] [Google Scholar]
  • 61. Psaltis PJ, Harbuzariu A, Delacroix S, Holroyd EW, Simari RD. Resident vascular progenitor cells–diverse origins, phenotype, and function. J Cardiovasc Transl Res. 2011;4:161‐176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Higa K, Kato N, Yoshida S, et al. Aquaporin 1‐positive stromal niche‐like cells directly interact with N‐cadherin‐positive clusters in the basal limbal epithelium. Stem Cell Res. 2013;10:147‐155. [DOI] [PubMed] [Google Scholar]
  • 63. Notara M, Shortt AJ, O'Callaghan AR, Daniels JT. The impact of age on the physical and cellular properties of the human limbal stem cell niche. Age (Dordr). 2013;35:289‐300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Li Y, Inoue T, Takamatsu F, et al. Differences between niche cells and limbal stromal cells in maintenance of corneal limbal stem cells. Invest Ophthalmol Vis Sci. 2014;55:1453‐1462. [DOI] [PubMed] [Google Scholar]
  • 65. Basu S, Hertsenberg AJ, Funderburgh ML, et al. Human limbal biopsy‐derived stromal stem cells prevent corneal scarring. Sci Transl Med. 2014;6:266ra172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Polisetti N, Zenkel M, Menzel‐Severing J, Kruse FE, Schlotzer‐Schrehardt U. Cell adhesion molecules and stem cell‐niche‐interactions in the limbal stem cell niche. Stem Cells. 2016;34:203‐219. [DOI] [PubMed] [Google Scholar]
  • 67. Hatou S, Yoshida S, Higa K, et al. Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/beta‐catenin signaling. Stem Cells Dev. 2013;22:828‐839. [DOI] [PubMed] [Google Scholar]
  • 68. Kureshi AK, Dziasko M, Funderburgh JL, Daniels JT. Human corneal stromal stem cells support limbal epithelial cells cultured on RAFT tissue equivalents. Sci Rep 2015;5:16186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Dominici M, Le BlancK, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315‐317. [DOI] [PubMed] [Google Scholar]
  • 70. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143‐147. [DOI] [PubMed] [Google Scholar]
  • 71. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post‐natal organs and tissues. J Cell Sci. 2006;119:2204‐2213. [DOI] [PubMed] [Google Scholar]
  • 72. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res. 2003;18:696‐704. [DOI] [PubMed] [Google Scholar]
  • 73. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol. 2007;9:255‐267. [DOI] [PubMed] [Google Scholar]
  • 74. Sacchetti B, Funari A, Michienzi S, et al. Self‐renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell. 2007;131:324‐336. [DOI] [PubMed] [Google Scholar]
  • 75. Schwab KE, Gargett CE. Co‐expression of two perivascular cell markers isolates mesenchymal stem‐like cells from human endometrium. Hum Reprod. 2007;22:2903‐2911. [DOI] [PubMed] [Google Scholar]
  • 76. Peault B, Rudnicki M, Torrente Y, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther. 2007;15:867‐877. [DOI] [PubMed] [Google Scholar]
  • 77. Haack‐Sorensen M, Friis T, Bindslev L, Mortensen S, Johnsen HE, Kastrup J. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest. 2008;68:192‐203. [DOI] [PubMed] [Google Scholar]
  • 78. Lozito TP, Kuo CK, Taboas JM, Tuan RS. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem. 2009;107:714‐722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R. Serum‐deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic. Stem Cell Res. 2011;6:215‐225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Steinbach SK, El‐Mounayri O, DaCosta RS, et al. Directed differentiation of skin‐derived precursors into functional vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2011;31:2938‐2948. [DOI] [PubMed] [Google Scholar]
  • 81. Bernardo ME, Cometa AM, Pagliara D, et al. Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol. 2011;24:73‐81. [DOI] [PubMed] [Google Scholar]
  • 82. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132:631‐644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Hardy SA, Maltman DJ, Przyborski SA. Mesenchymal stem cells as mediators of neural differentiation. Curr Stem Cell Res Ther. 2008;3:43‐52. [DOI] [PubMed] [Google Scholar]
  • 84. Wu J, Du Y, Mann MM, Yang E, Funderburgh JL, Wagner WR. Bioengineering organized, multilamellar human corneal stromal tissue by growth factor supplementation on highly aligned synthetic substrates. Tissue Eng Part A. 2013;19:2063‐2075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Xu RH, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2:185‐190. [DOI] [PubMed] [Google Scholar]
  • 86. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self‐renewal in collaboration with STAT3. Cell. 2003;115:281‐292. [DOI] [PubMed] [Google Scholar]
  • 87. Han B, Chen SY, Zhu YT, Tseng SC. Integration of BMP/Wnt signaling to control clonal growth of limbal epithelial progenitor cells by niche cells. Stem Cell Res. 2014;12:562‐573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Afsharkhamseh N, Movahedan A, Gidfar S, et al. Stability of limbal stem cell deficiency after mechanical and thermal injuries in mice. Exp Eye Res. 2016;145:88‐92. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES